Investing in the healthcare sector depends heavily on individual risk tolerance, portfolio asset allocation strategies, and prevailing macroeconomic conditions. Healthcare is traditionally viewed as a defensive sector due to inelastic demand for essential medical services, pharmaceuticals, and diagnostics during economic downturns. However, investors must navigate complex regulatory environments, pricing pressures, patent expirations for major drug portfolios, and fluctuating government healthcare funding models, making selective stock picking essential for capturing long-term growth.